EGF Upregulates, Whereas TGF-β Downregulates, the Hyaluronan Synthases Has2 and Has3 in Organotypic Keratinocyte Cultures: Correlations with Epidermal Proliferation and Differentiation  by Pasonen-Seppänen, Sanna et al.
ORIGINAL ARTICLE
EGF Upregulates,Whereas TGF-b Downregulates, the
Hyaluronan Synthases Has2 and Has3 in Organotypic
Keratinocyte Cultures: Correlations with Epidermal
Proliferation and Di¡erentiation
Sanna Pasonen-Seppnen, Susanna Karvinen, Kari T˛rr˛nen, Juha M. T. Hyttinen,Tiina Jokela, Mikko J. Lammi,
Markku I. Tammi, and Raija Tammi
Department of Anatomy, University of Kuopio, Kuopio, Finland
Hyaluronan, a major extracellular matrix molecule
in the vital cell layers of skin epidermis, has been
suggested to support proliferation and migration of
keratinocytes, during challenges like wounding and in-
£ammation. An organotypic keratinocyte culture origi-
nated from continuous rat epidermal keratinocyte cell
line was subjected to the proliferative and antiprolifera-
tive growth factors epidermal growth factor and trans-
forming growth factor b, respectively, to study their
in£uence on hyaluronan synthesis and epidermal mor-
phology. Epidermal growth factor induced a 4-fold
increase of epidermal hyaluronan concentration. This
was associated with upregulation of the hyaluronan
synthases Has2 and Has3, and the hyaluronan receptor
CD44. 5-Bromo-20 -deoxyuridine labeling, basal cell
height, and the thickness of vital epidermis were in-
creased, re£ecting the hyperplastic e¡ects of epidermal
growth factor. The expression of keratin 10 and the
maturation of ¢laggrin were inhibited, and epidermal
permeability barrier became less e⁄cient, indicating
compromised terminal di¡erentiation by epidermal
growth factor. In contrast, transforming growth factor
b reduced the content of hyaluronan and the mRNA of
Has2 and Has3. At the same time, transforming growth
factor b suppressed keratinocyte proliferation and epi-
dermal thickness, but retained intact di¡erentiation.
The results suggest that epidermal hyaluronan synthe-
sis, controlled by epidermal growth factor and transform-
ing growth factor b through changes in the expression
of Has2 and Has3, correlates with epidermal prolifera-
tion, thickness, and di¡erentiation. Key words: CD44/
¢laggrin/Has2/Has3/keratin 10. J Invest Dermatol 120:
1038 ^1044, 2003
T
he structure and function of epidermis depend on a
controlled balance between keratinocyte prolifera-
tion and di¡erentiation, disturbed in pathologic si-
tuations like wounding (Stoscheck et al, 1992) and
psoriasis (King et al, 1990). Both in the normal and
diseased epidermis, keratinocyte growth and di¡erentiation are
regulated by autocrine and paracrine signaling molecules such as
members of the epidermal growth factor (EGF), ¢broblast
growth factor (FGF), and transforming growth factor b (TGF-b)
families (Eckert et al, 1997; Hashimoto, 2000). For example, by
stimulation of the human EGF receptor, keratinocytes proliferate
faster, degrade extracellular matrix components, and become mi-
gratory (Nickolo¡ et al, 1988; Chen et al, 1993), whereas TGF-b
inhibits keratinocyte proliferation (Alexandrow and Moses,
1995a). The expression patterns, and regulation during keratino-
cyte growth and di¡erentiation, are well documented for many
cytoskeletal proteins (Presland et al, 2001) but less is known on
the role of cell surface and extracellular molecules in these
processes.
Hyaluronan, a large unsulfated glycosaminoglycan, is ex-
pressed by many cell types and contributes to cellular functions
such as adhesion, proliferation, migration, and di¡erentiation by
its unique physicochemical properties and interactions with spe-
ci¢c cell surface receptors (for a recent review, see Tammi et al,
2002). Hyaluronan staining is abundant on the surface and be-
tween the basal and spinous cell layers of normal human epider-
mis, but virtually absent in the terminally di¡erentiated layers
(Tammi et al, 1988; —gren et al, 1997). Other strati¢ed epithelia like
that of mouth (Tammi et al, 1990) and esophagus (Wang et al,
1996) show a hyaluronan distribution similar to that in epidermis,
whereas hyaluronan is not detected in most simple epithelia
(Wang et al, 1996). This distribution suggests that hyaluronan is
important for the strati¢ed epithelia and their di¡erentiation. Ac-
cordingly, large alterations in hyaluronan synthesis rate have been
observed in human skin organ cultures by retinoic acid (Tammi
et al, 1989) and corticosteroids (—gren et al, 1995), both known for
their powerful in£uences on keratinocyte proliferation and di¡er-
entiation. Recently, direct evidence on the role of hyaluronan in
epidermal keratinocytes emerged by the ¢nding that hyaluronan
synthesis (Has2 expression) controls the migration rate of kerati-
nocytes in scratch-wounded monolayer cultures (Rilla et al,
2002).
Growth factors are known to control hyaluronan synthesis;
however, the in£uence seems to be speci¢c for each cell type,
and may also depend on the stage of the cellular di¡erentiation.
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Thus, TGF-b stimulates hyaluronan production in ¢broblasts
(Sugiyama et al, 1998), but was recently reported to inhibit
hyaluronan synthesis in human keratinocytes (Sayo et al, 2002).
Studies on rat epidermal keratinocytes cultured as monolayers have
suggested that elevated hyaluronan synthesis is an important fea-
ture of the EGF response (Pienimki et al, 2001). There are no pre-
vious reports on the in£uences of EGF and TGF-b on hyaluronan
synthesis in the keratinocytes of structurally normal epidermis.
This work explores the e¡ects of a mitogenic growth factor,
EGF, and that of an antiproliferative growth factor, TGF-b, on
hyaluronan metabolism and epidermal morphology in an orga-
notypic keratinocyte culture with normal epidermal tissue archi-
tecture. The results show that hyaluronan concentration is closely
correlated with the proliferative activity and volume of the vital
part of the epidermis, and inversely related with the markers of
di¡erentiation, suggesting that hyaluronan synthesis regulated by
Has2 and Has3 is an important component in the proliferative
reactions of epidermis and is also involved in the epidermal dif-
ferentiation process.
MATERIALS AND METHODS
Cell culture A keratinocyte cell line derived from newborn rat skin
(REK, rat epidermal keratinocyte) was used (Baden and Kubilus, 1983).
The stock cultures were grown in minimum essential medium (Life
Technologies, Paisley, U.K.) with 10% fetal bovine serum (HyClone,
Logan, UT), 4 mM L-glutamine (Sigma, St. Louis, MO), 50 mg per ml
streptomycin sulfate, and 50 U per ml penicillin (Sigma) at 371C in
humidi¢ed 95% air/5% CO2. REKs were passaged twice a week at a 1:5
split ratio using 0.05% trypsin (wt/vol), 0.02% ethylenediamine tetraacetic
acid (EDTA) (wt/vol) in phosphate-bu¡ered saline (PBS). For organotypic
cultures, REKs were cultured at the air^liquid interface on type I collagen
support (from rat tail) as described in Pasonen-Seppnen et al (2001). The
culture medium was supplemented with EGF (2^20 ng per ml; Sigma) or
TGF-b1 (1^4 ng per ml; Life Technologies) from the day after the culture
was raised to the air^liquid interface. The cultures for these studies were
grown for 2^3 wk, with the medium changed every 2 d for the ¢rst
week and daily thereafter.
Histology and morphometry The organotypic cultures were ¢xed in
2% bu¡ered paraformaldehyde containing 0.5% glutaraldehyde, or in
Histochoices (Amresco, Solon, OH) overnight, washed with 0.1 M
sodium phosphate bu¡er (PB), pH 7.4, dehydrated in graded ethanol,
embedded in para⁄n, and cut into 3 mm thick vertical sections.
The morphometric measurements were performed on hematoxylin/
eosin stained sections with the NIH-Image 1.62/fat software for
Macintosh. The cultures were systematically sampled by taking 10 digital
images with a CoolSNAP camera (Photometrics) from each culture at
constant distances in each section using a 20 objective and an 1.25
intermediate lens (Nikon Microphot FXA microscope, Japan). The
thickness of the vital cell layers, the thickness of the stratum corneum,
and the height of the basal cells were recorded. In stratum corneum
measurements, thresholding of areas exhibiting background intensity was
used to exclude the space between separated corneocytes.
Immunocytochemistry Histochoices-¢xed, depara⁄nized sections
were ¢rst incubated in target unmasking £uid (TUFt, Monosan, Uden,
The Netherlands) at 951C and then for 5 min with 1% H2O2 to block
endogenous peroxidase, washed with PB, and incubated in 1% bovine
serum albumin (BSA) in PB for 30 min to block nonspeci¢c binding.
Thereafter the sections were incubated overnight at 41C with monoclonal
antikeratin 10 (1:10 dilution in 1% BSA) (Monosan), polyclonal
anti¢laggrin (1:5000 dilution) (a generous gift of Dr. Beverly Dale-
Crunk, University of Washington, Seattle, WA), or monoclonal anti-
CD44 antibody (OX50; Biosource, Camarillo, CA), followed by a 1 h
incubation with biotinylated antimouse antibody (dilution 1:50) (Vector
Laboratories, Burlingame, CA) or biotinylated antirabbit antibody
(dilution 1:70) (Vector Laboratories), respectively. The bound antibodies
were visualized with the avidinbiotin peroxidase method (1:200
dilution, Vectastain Kit, Vector Laboratories). The sections were incubated
for 5 min in 0.05% 3,30 -diaminobenzidine (Sigma) and 0.03% hydrogen
peroxide in PB. After washes, the sections were counterstained with
Mayer’s hematoxylin for 1 min, washed, dehydrated, and mounted in
DPX (Gurrs, BDH Laboratory Supplies, Poole, U.K.). The controls
included sections treated in the same way but with the primary antibody
omitted.
Histochemical demonstration of hyaluronan and CD44 Hyaluronan
staining was done to paraformaldehyde (2%)glutaraldehyde (0.5%) ¢xed
cultures with a speci¢c probe, biotinylated hyaluronan binding complex
(bHABC), puri¢ed from a 4 M guanidineHCl extract of bovine
articular cartilage after dialysis and trypsin digestion as described
previously (Tammi et al, 1994). The speci¢city of the staining was
controlled by preincubating the sections with Streptomyces hyaluronidase
to remove hyaluronan from the tissue (Tammi et al, 1989).
Intracellular hyaluronan was detected using confocal microscopy.
Depara⁄nized, TUF-treated sections were incubated for 30 min with 50
mM glycine to block auto£uorescence, washed with PB, and incubated in
1% BSA in PB for 30 min to block nonspeci¢c binding. For double
staining, the anti-CD44 monoclonal antibody (1:20) was added to the
bHABC solution (5 mg per ml), and sections were incubated overnight at
41C, washed, and incubated simultaneously with Texas-Red-labeled
antimouse antibody (1:50) and £uorescein isothiocyanateavidin (1:1000)
for 1 h at room temperature. The sections were coverslipped using
Vectashield (Vector) mounting medium. The micrographs were obtaind
with an Ultraviews confocal scanner (Perkin Elmer Life Sciences,
Wallac-LSR, Oxford, U.K.) on a Nicon Eclipse TE300 microscope using
a 100 oil immersion objective.
Proliferation assay Two-week-old REK cultures were incubated with
5-bromo-20 -deoxyuridine (BrdU) for 1 h, washed with PBS, and ¢xed
overnight in Histochoices. Depara⁄nized, TUF-treated sections were
incubated at 951C, immunostained with the anti-BrdU antibody, and
counterstained with propidium iodide (0.01 mg per ml; Sigma) according
to the instructions of the manufacturer (5-Bromo-20 -deoxyuridine
Labeling and Detection Kit I, Roche Diagnostics Corporation, IN).
Approximately 10 ¢elds per section were counted for the labeled cells in
six separate experiments with a Nikon Microphot FXA microscope using
a 10 objective lens.
Hyaluronan assay Serum-free medium (1.5 ml) otherwise identical
with that used in the organotypic cultures was changed 24 h before the
assay to exclude the hyaluronan introduced by serum. Medium,
epidermis, and collagen support were each analyzed, the last two after
separation with ¢ne tweezers. Epidermis and collagen were extracted
twice with 2 ml of acetone at 41C for 1 d. The lipid extracts were
discarded and the samples were dried in air before weighing. The
epidermis was digested with 200 ml of a solution containing 250 mg per
ml papain (Sigma) in 5 mM cysteine and 5 mM EDTA at 601C
overnight, and the collagen matrix with 550 ml of the same solution but
with 400 mg per ml papain. After digestion, the samples were boiled for
10 min to inactivate the enzyme, centrifuged, and the precipitates were
discarded. Medium (1.5 ml) and the digests were diluted (1:100^1:300)
with 1% BSA in PBS before the assay.
Ninety-six-well Maxisorp Plates (Nunc, Roskilde, Denmark) were
coated with 1 mg per ml of the HABC overnight at 41C. After
incubation, the plates were washed 33 min with PBS containing 0.5%
Tween (Tween-PBS) and blocked with 1% BSA for 1 h at 371C.
Standard hyaluronan (1^50 ng per ml; Proviscs, Algon Laboratories,
Fort Worth, TX) and samples were diluted into 1% BSA in PBS, and 100
ml aliquoted to the wells. After 1 h incubation at 371C, the plates were
washed with Tween-PBS, incubated with 1 mg per ml bHABC for 1 h at
371C, and washed 33 min with Tween-PBS. Then 100 ml of horseradish
peroxidase streptavidin complex (Vector) was added and allowed to stand
for 1 h at 371C. After washing 53 min with Tween-PBS, 100 ml of 1 mg
per ml of O-phenylenediamine dihydrochloride (Sigma) 0.03% H2O2 in
0.1 M phosphate citrate bu¡er, pH 5, was added and kept at 371C. The
reaction was stopped after 15 min by adding 50 ml of 8 N H2SO4 and the
absorbances were read at 490 nm. Each sample and standard were analyzed
in triplicate.
Reverse transcriptase polymerase chain reaction (RT-PCR) For
RT-PCR, total RNA was isolated from 2-wk-old organotypic REK
cultures with TRIzols-reagent (Gibco) according to the instructions of
the manufacturer. The samples were DNase treated, and equal amounts of
RNAwere taken for the RT-PCR done with the GeneAmps Gold RNA
PCR Reagent Kit (Applied Biosystems, CA). The primers used for
the RT-PCR of rat Has1, Has2, Has3, CD44, pro¢laggrin, and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), the annealing
temperatures, and the number of PCR cycles are shown in Table I.
The RT-PCR products separated on 1.5% agarose gels were digitized
by BioDocIIt Video Documentation system (Biometra, G˛ttingen,
Germany), and the band densities were compared with the NIH-Image
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1.62/fat software. The pixel density of the electrophoretic band obtained by
image analysis is not linearly correlated with the actual level of mRNA or
cDNA in the sample. Still, the values, when divided by that from GAPDH
of the same mRNA isolate, can be used for normalization to indicate
whether there is an increase or decrease in the level of expression.
Gel electrophoresis and immunoblot analysis The organotypic
REK cultures (epidermis without collagen matrix) were rinsed
with ice-cold PBS, homogenized in 8 M urea, 50 mM Tris pH 7.6,
100mM dithiothreitol, 0.13 M 2-mercaptoethanol, 100 mg per ml
phenylmethylsulfonyl £uoride, and 100 mg per ml aprotinin (Haydock
et al, 1993) with Ultra Turrax (Ystral, Germany), and centrifuged at 13,000g
for 5 min, and the pellets were discarded. From the supernatant, equal
amounts of protein (Bradford, 1976) were separated by 10% sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and
transferred onto Immobilont-NC membranes (Millipore, Bedford, MA)
by 3.5 mA per cm2 constant current with Sammyt semidry blotter
(Schleicher & Schuell, Dassel, Germany). Nonspeci¢c binding was
blocked by 5% fat-free milk powder and 0.2% Tween 20 in 10 mM Tris,
150 mM NaCl, pH 7.4 (Tris-saline blocking bu¡er) overnight at 41C. The
membranes were incubated for 2 h with the polyclonal anti¢laggrin
(1:9000) and the monoclonal antikeratin 10 (1:100) antibodies described
above, both diluted with the blocking bu¡er. The membranes were
washed four times for 15 min with 0.2% Tween 20 in the Tris-saline
bu¡er, incubated for 1 h with 1:20,000 dilution of horseradish peroxidase
conjugated secondary antibody  antirabbit IgG (Zymed Laboratories,
CA) for ¢laggrin and antimouse IgG (Santa Cruz Biotechnology, Santa
Cruz, CA) for keratin 10  and washed four times with 0.2% Tween 20
in Tris-saline bu¡er. The immune complexes were visualized using the
NENt chemiluminescence detection kit according to the manufacturer’s
instructions (Life Science Products, Boston, MA).
Permeability studies The permeability of the organotypic cultures was
tested in two-chamber di¡usion cells (Side-by-Side; Crown Glass,
Somerville, NJ) with a 3 ml volume in each compartment and an
e¡ective di¡usional area of 0.64 cm2, as described previously (Pasonen-
Seppnen et al, 2001). Brie£y, the culture was clamped between the
chambers ¢lled with PBS and equilibrated at 371C. The tritiated
corticosterone (NEN Life Science Products; 20,000^40,000 dpm per 10 ml)
was added to the donor chamber, and aliquots were withdrawn repeatedly
from the acceptor side for liquid scintillation counting. The permeability
coe⁄cient (p; cm per s) for the probe permeant was calculated at steady
state under sink conditions by dividing the steady state £ux (dpm per s
cm2) through the skin by the concentration of the test substance (dpm per
cm3) in the donor phase.
Statistical analysis The signi¢cances of the di¡erences between the
groups in the morphometric and hyaluronan assay measurements and
in RT-PCR were tested using the paired samples t test. The data
from proliferation and permeability assays were analyzed with the
nonparametric Mann^Whitney U test. A di¡erence was considered
statistically signi¢cant when the associated p-value was less than 0.05.
RESULTS
Opposite in£uences of EGF and TGF-b on epidermal
morphology and proliferation After 2 wk, REKs seeded on
a collagen lattice and lifted to the air^liquid interface formed a
histologically normal looking epidermis with a basal cell layer,
two to four spinous cell layers, and one granular cell layer under
a well developed stratum corneum (Fig 1A, Control), as
described previously (MacCallum and Lillie, 1990; Pasonen-
Seppnen et al, 2001). Cultures grown in the presence of EGF
exhibited a dose-dependent stimulation of proliferation as
indicated by BrdU labeling (Fig 1B). Accordingly, EGF-treated
Table I. Primers, annealing temperatures, and number of cycles used in the RT-PCR
Has1 50 -GCT CTATGG GGC GTT CCT C-30 (left) 571C 35^37
50 -CAC ACATAA GTG GCA GGG TCC-30 (right)
Has2 50 -TCG GAACCACAC TGT TTG GAG TG-30 621C 33^35
50 -CCA GAT GTA AGT GAC TGATTT GTC CC-30
Has3 50 -ACT CTG CAT CGC TGC CTACC-30 661C 33
50 -ACATGACTT CAC GCT TGC CC-30
CD44 50 -TTG GGG ACTACT TTG CCT CTTA-30 551C 33
50 -CCA CTG CTG ACATCC TCATCTA-30
Pro¢laggrin 50 -CTC AGG GCATCG CTC GTC A-30 641C 34
50 -GCT GGT GGC GGT CTT CGT G-30
GAPDH 50 -TGATGC TGG TGC TGA GTATG-30 601C 32
50 -GGT GGA AGA ATG GGA GTT GC-30
Figure1. In£uence of EGF and TGF-b on epidermal growth and
morphology. (A) Two-week-old organotypic REK cultures grown in
the presence of EGF (20 ng per ml) and TGF-b (4 ng per ml) were ¢xed,
processed for para⁄n sectioning, and stained with hematoxylin and eosin.
Scale bar: 25 mm. (B) Two-week-old cultures were incubated with BrdU for
1 h and the labeled cells were visualized and counted per microscopic ¢eld
as described in Materials and Methods. The data represent means7SEM
of four to 10 experiments. Statistical signi¢cance between control
and growth-factor-treated cultures, npo0.05 (Mann^Whitney U test). (C)
Two-week-old organotypic REK cultures were analyzed by morphometry
as described in Materials and Methods. The data represent means7SEM of
six experiments. npo0.05, paired samples t test.
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cultures showed taller basal cells and hypertrophy of the whole
vital part of the epidermis, whereas stratum corneum was
relatively thin (Fig 1A, C). In the EGF-treated cultures BrdU-
labeled nuclei were also found in the suprabasal compartment,
whereas in control cultures the cells in the S-phase of the cell
cycle were located in the basal cell layer (data not shown).
Conversely, the cultures containing 4 ng per ml TGF-b showed
signi¢cantly fewer labeled cells than control cultures (Fig 1B).
These results, indicating a lower proliferation rate, are in line
with a decline in the thickness of the epidermis (Fig 1A, C), and
with previous reports on TGF-b (Nickolo¡ et al, 1988;
Alexandrow and Moses, 1995b).
Epidermal hyaluronan synthesis is increased by EGF and
decreased by TGF-b In 2-wk-old control cultures, the
concentration of hyaluronan in the epidermis was E150 ng per
mg of tissue dry weight. The collagen matrix and medium, into
which a part of the hyaluronan escapes (Tammi et al, 2000),
containedE2800 ng per mg of tissue dry weight.
EGF caused a dose-dependent increase of hyaluronan in the
epidermis (Fig 2A). A large deposition of hyaluronan was also
found in the collagen and medium (Fig 2A). At 2 ng per ml,
EGF caused an approximately equal increase in both com-
partments (1.7  control), whereas at the higher concen-
tration (20 ng per ml) the increase in the matrix compartment
was more obvious than in the epidermis (4.9 and 3.7,
respectively), suggesting enhanced out£ow from the epidermis
when the synthesis rate is elevated.
In the TGF-b-treated cultures (4 ng per ml) the epidermal
hyaluronan concentration was similar to that in control cultures
(Fig 2A) the hyaluronan content of the matrix compartment
was signi¢cantly lower than in the control cultures. However
(Fig 2A). Thus, less hyaluronan escaped from the tissue, a
situation obviously resulting from reduced synthesis in the
epidermis or increased degradation.
EGF increases and TGF-b reduces Has2 and Has3
mRNA RNA isolated from 2-wk-old organotypic cultures
was subjected to RT-PCR of Has1, Has2, Has3, and CD44, and
their signals were compared with that of GAPDH. The
expression level of Has1 was very low in organotypic REK
cultures and in three out of ¢ve experiments the band densities
were too weak to measure. Those available showed no change
with either EGF or TGF-b, however (data not shown). EGF
increased the levels of Has2 and Has3 mRNA signi¢cantly at
both 2 and 20 ng per ml concentrations (Fig 2B). In contrast,
the expression of both Has2 and Has3 isoenzymes was
signi¢cantly reduced at the higher TGF-b concentration
(Fig 2B).
The size of the RT-PCR product suggested that REKs in
organotypic culture mainly expressed the standard form of
CD44, both under control conditions and after the growth
factor treatments (data not shown). The level of CD44 mRNA
was signi¢cantly stimulated with the higher dose of EGF.
Although the changes in the levels of CD44 appeared modest in
the TGF-b-treated cultures, there was a tendency for decrease
with the higher dose of TGF-b (Fig 2B).
Distribution of hyaluronan and CD44 in the organotypic
epidermis Hyaluronan was found in all vital cell layers, with
the highest staining intensity in the spinous layer (Fig 3A), as
described previously (Tammi et al, 2000). The cultures treated
with EGF showed a marked increase in hyaluronan staining,
most intense in the spinous cell layers (Fig 3C). In addition to
the pericellular (cell-surface-associated) hyaluronan, there was
often a speci¢c, quite abundant intracellular hyaluronan staining
in the EGF-treated cultures (Fig 3C, arrow). This location was
con¢rmed by confocal microscopy using dual staining with
bHABC and CD44, the latter visualizing the plasma membranes
(Fig 3G, H). Furthermore, in EGF-treated cultures hyaluronan
resided in stratum corneum (Fig 3C, asterisk), a location com-
pletely negative in control cultures (Fig 3A). Whereas TGF-b
reduced the number of vital (hyaluronan-positive) cell layers, it
had little if any in£uence on hyaluronan staining intensity or
distribution in the epidermis (Fig 3E).
Immunostaining of the hyaluronan receptor CD44 in control
cultures showed a relatively weak signal, mostly localized in the
basal and lower spinous layers (Fig 3B). TGF-b did not change
this pattern (Fig 3F). This was in contrast to EGF, which
markedly increased the CD44 staining intensity, especially in
the basal cell layer (Fig 3D, arrow). The CD44 signal was also
detected in the collagen support of the EGF-treated cultures,
suggesting that EGF enhanced the shedding of CD44 from the
basal cells (Fig 3H, arrowheads).
Inhibition of epidermal di¡erentiation by EGF To correlate
the changes in hyaluronan synthesis rate with epidermal
di¡erentiation, the di¡erentiation markers keratin 10 and
¢laggrin were studied using immunocytochemistry andWestern
blots. In control cultures, keratin 10 was detectable in all
suprabasal cell layers, with the highest staining intensity in the
granular layer, whereas the highest signal of ¢laggrin was found
in the granular layer and in the corni¢ed cells (Fig 4A, B). The
staining intensity for both keratin 10 and ¢laggrin was reduced in
the EGF-treated cultures, and this reduction was even more
prominent for the early di¡erentiation marker keratin 10 than
¢laggrin (Fig 4C, D). Besides the reduced general staining
Figure 2. EGF stimulates and TGF-b inhibits epidermal hyaluronan
production by regulating the expression of Has genes. (A) Hyaluro-
nan concentration was separately determined in the epidermal tissue, sup-
porting collagen matrix, and culture medium in 2-wk-old cultures using
the ELISA-like assay described in Materials and Methods. The results are ex-
pressed as percent of the untreated control cultures (means7SEM).
nnpo0.01, nnnpo0.001, paired samples t test. (B) Equal amounts of RNA
extracted from 2-wk-old organotypic REK cultures were subjected to RT-
PCR with primers speci¢c for the di¡erent Has isoforms, CD44, and
GAPDH. In each experiment, the Has or CD44/GAPDH pixel density ra-
tio from the growth-factor-treated culture was expressed as a percentage of
that in the control culture. The value in parentheses under each column
shows the number of experiments. The error bar indicates7SEM.
npo0.05, paired samples t test.
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intensity, the number of keratin-10-positive cell layers was also
reduced in EGF-treated specimens compared to controls and the
staining was mainly restricted to the granular cell layer/corni¢ed
layer boundary (Fig 4D, arrow). TGF-b had minor e¡ects on the
general staining intensity of keratin 10 and ¢laggrin. In TGF-b-
treated cultures, ¢laggrin was localized to the same cell layer as
in control cultures, whereas keratin 10 was mostly shifted to
stratum corneum (Fig 4F, arrow).
Western blot analyses con¢rmed the results obtained with the
immunohistochemistry. In specimens prepared from EGF-treated
cultures, the E57 kDa band representing keratin 10 had almost
disappeared (Fig 5A). The blots with the anti¢laggrin antibody
indicated that EGF did not in£uence the high molecular weight
band representing pro¢laggrin, but, as indicated by the loss of
the E42 kDa band, it almost completely blocked processing
of pro¢laggrin into its mature low molecular weight form
(Fig 5A). TGF-b-treated samples produced Western blots very
similar to those of the controls with both anti¢laggrin and
antikeratin 10 antibodies (Fig 5A). RT-PCR for pro¢laggrin
mRNA revealed no major changes with either EGF or TGF-b
(Fig 5B), a result largely in line with the Western blot of
pro¢laggrin (Fig 5A).
Epidermal permeability is increased by EGF Transepidermal
permeability is a functional indicator of the epidermal
di¡erentiation. The present organotypic culture forms a very
e⁄cient permeability barrier for commonly used tracers like
tritiated corticosterone (Pasonen-Seppnen et al, 2001). The
organotypic epidermis grown in the presence of 20 ng per ml of
EGF showed a considerably higher rate of tracer di¡usion
through the epidermis, whereas the permeability of TGF-b-
treated cultures was similar to those of control cultures (Fig 5C).
These ¢ndings give further support to the conclusion that EGF
retarded the di¡erentiation of REKs in organotypic cultures,
whereas TGF-b had only a minor in£uence on the dif-
ferentiation parameters.
Figure 3. Distribution of hyaluronan and CD44 in EGF- and TGF-b-treated cultures. After 2 wk growth in the absence or presence of the growth
factors, the cultures were processed for the cytochemical stainings for hyaluronan and CD44. Hyaluronan is mostly localized in the spinous cell layer
(A) whereas CD44 is found in the spinous and basal cell layer, but the staining intensity is low in control cultures (B). In EGF (20 ng per ml) treated
cultures, hyaluronan (C) and CD44 expression (D) are elevated (arrows) and some hyaluronan appears in the stratum corneum (asterisk in C). TGF-b (4 ng
per ml) had minor e¡ects on epidermal hyaluronan staining (E) and CD44 expression (F). Control (G) and EGF-treated (H) cultures were double-stained
for CD44 (red) and hyaluronan (green), and viewed by confocal microscopy. CD44 is almost entirely located on cell surfaces, often colocalizing with hyalur-
onan (yellow signal). The red staining in the granular and corni¢ed layers represents unspeci¢c signal associated with auto£uorescence. An extensive amount
of intracellular hyaluronan resides in the spinous cell layer of the EGF-treated culture (arrow in H). Some hyaluronan and CD44 are also found in the
collagen matrix of the EGF-treated cultures (arrowheads in H). Scale bars: (A)(F) 50 mm; (G)(H) 20 mm.
Figure 4. EGF and TGF-b change the localization of keratin 10 and
¢laggrin. Cultures grown for 2 wk in control conditions (A, B), in the
presence of 20 ng per ml EGF (C, D), and in the presence of 4 ng per ml
TGF-b (E, F) were stained with antibodies for ¢laggrin (A, C, E) and ker-
atin 10 (B, D, F). Note that the signal for keratin 10 is low in the presence
of EGF (arrow in D), and mostly shifted into stratum corneum byTGF-b
(arrow in F). Scale bar: 50 mm.
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DISCUSSION
This work indicates that EGF andTGF-b regulate hyaluronan ex-
pression in an organized, multilayered epidermal tissue, resulting
in stimulation and inhibition of hyaluronan synthesis, respec-
tively. Further, the data show that the enhanced hyaluronan pro-
duction in EGF-treated cultures was due to upregulation of Has2
and Has3, whereas the inhibition byTGF-b was due to downre-
gulation of the same Has genes. These and our previous results
indicate that the regulation of the di¡erent Has types by growth
factors depends on the state of keratinocyte di¡erentiation. In the
organotypic cultures here, there was a signi¢cant increase of Has2
and Has3 by EGF, whereas Has2 was preferentially induced in the
same REK cells cultured as nondi¡erentiating monolayers (Pieni-
mki et al, 2001). Also, the expression of Has1 appeared relatively
lower in these organotypic cultures than in monolayers (Pienimki
et al, 2001).
All Has isoenzymes are expressed in the monolayers of rat ker-
atinocytes (Pienimki et al, 2001), whereas human keratinocytes
are reported to express only Has1 and Has3 (Sayo et al, 2002)
and mouse keratinocytes at least Has1 and Has2 (Sugiyama et al,
1998). In line with our ¢ndings, TGF-b suppresses Has3 expres-
sion in human keratinocytes (Sayo et al, 2002), but, surprisingly,
upregulates Has1 in mouse keratinocytes (Sugiyama et al, 1998).
The apparent species di¡erences in both the basal expression pat-
tern and the cytokine/growth factor induced changes of the three
Has enzymes in epidermal keratinocytes need to be addressed in a
comparative study to exclude potentially important variations in
the experimental setup.
The epidermal morphology was correlated with the hyaluro-
nan production in that a high hyaluronan content was observed
in EGF-treated cultures with tall basal cells, elevated proliferation
rate, and increased thickness of spinous cell layer. In contrast, a
slightly atrophic epidermis in TGF-b-treated cultures, with low
proliferation rate and few suprabasal vital cell layers, was asso-
ciated with reduced hyaluronan content in the matrix. The idea
of hyaluronan contributing to the regulation of epidermal thick-
ness and keratinocyte proliferation rate receives support from ear-
lier studies on human skin organ cultures, indicating that
hydrocortisone inhibits hyaluronan synthesis and simultaneously
reduces keratinocyte proliferation and epidermal thickness
(—gren et al, 1995).This is in line with the fact that glucocorticoids
are powerful downregulators of Has2 mRNA (Jacobson et al,
2000; Zhang et al, 2000). Furthermore, retinoic acid, while stimu-
lating epidermal hyaluronan synthesis, also increases the number
of spinous cell layers (Tammi et al, 1985). Hyaluronan synthesis is
thus positively correlated with keratinocyte proliferation and the
thickness of the vital epidermis. Direct evidence for the impor-
tance of hyaluronan synthesis in keratinocyte proliferation was
recently provided in experiments where inhibition of hyaluronan
synthesis by transfection of an antisense Has2 gene caused a delay
in the entry of the S-phase of the cell cycle (Rilla et al, 2002).
Although there was a clear increase of hyaluronan in the basal,
proliferative cell layer of the EGF-treated epidermis, the most
conspicuous deposition was found in the upper spinous cell
layers, the site of initiation of terminal di¡erentiation. It was not
surprising, therefore, that di¡erentiation was a¡ected in the EGF-
treated cultures, as indicated by the inhibition of keratin 10 ex-
pression, ¢laggrin maturation, and epidermal permeability
barrier formation. A similar accumulation of hyaluronan in the
upper spinous cell layer and delayed di¡erentiation has been de-
scribed in human skin explants treated with retinoic acid (Tammi
et al, 1985; 1989). It should be noted that TGF-b, despite its strik-
ing e¡ects on the epidermal thickness, had little in£uence on the
amount of keratin 10, ¢laggrin, and permeability, correlating
with the unchanged hyaluronan concentration in the epidermis.
In the fetal epidermis, the beginning of adult-type terminal dif-
ferentiation is associated with the loss of hyaluronan from the
upper epidermis (—gren et al, 1997).
It remains to be elucidated whether hyaluronan synthesis and
concentration alone can in£uence the processes that take place
when keratinocytes are assembled into the corni¢ed sheets form-
ing the permeability barrier. It is easy to imagine how this bulky,
highly hydrophilic polymer, however, if not removed in time,
would interfere with the organization of the intercellular lipids
that form an important part of the permeability barrier. Further-
more, the greatly increased intracellular hyaluronan in the upper
spinous cells might disturb pro¢laggrin maturation. Hyaluronan
is known to in£uence the di¡erentiation of other cells in a man-
ner dependent on ErbB receptor signaling (Camenisch et al,
2002), and in monolayer cultures it modi¢es keratinocyte shape
and enhances migratory activity (Rilla et al, 2002). It appears that
the Has enzymes belong to a set of genes that need to be shut o¡
and hyaluronan degraded before the conversion of the upper spi-
nous cells into normal corneocytes can take place. Accordingly,
induction of di¡erentiation in epidermal keratinocytes by ele-
vated extracellular Ca2þ concentration was associated with a ra-
pid decrease of hyaluronan synthesis (Lamberg et al, 1986) and a
25-fold increase in hyaluronidase activity (Frost and Stern, 1997).
Terminal di¡erentiation thus correlates with reduced synthesis
and increased clearance of hyaluronan.
The mRNA levels of CD44, a major hyaluronan receptor in
epidermal keratinocytes (Tammi et al, 1998), was modulated in a
pattern somewhat resembling that of Has2 and Has3, i.e., with an
Figure 5. EGF inhibits keratinocyte di¡erentiation. (A) Western blots
with antibodies against rat ¢laggrin and keratin 10. The bands at 215 kDa
and 42 kDa show pro¢laggrin and mature ¢laggrin, respectively. The ¢g-
ure represents one of two separate experiments with equivalent results. (B)
RT-PCR analysis of pro¢laggrin mRNA levels from 2-wk-old REK cul-
tures analyzed and expressed as in Fig 2(B). (C) The permeability of corti-
costerone in cultures grown for 3 wk with 20 ng per ml EGF and 4 ng per
ml TGF-b. The data represent means7SD, and the number of experiments
is shown in parentheses under each column. Statistical signi¢cance be-
tween control and EGF-treated cultures, nnpo0.01, Mann^Whitney U test.
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upregulation by EGF and a tendency to downregulation byTGF-
b. The increase of CD44 protein by EGF was apparently re-
stricted to the basal cells, the main location of EGF receptors in
normal human epidermis (Nanney et al, 1990). CD44 is involved
in the organization of the pericellular hyaluronan matrix, inter-
nalization of hyaluronan (Tammi et al, 2001; Knudson et al,
2002), and mediation of hyaluronan-induced signals for prolifera-
tion and migration (Ichikawa et al, 1999; Ahrens et al, 2001). Ac-
cordingly, transgenic mice expressing an antisense CD44 under
the promoter of keratin 5 did not exhibit a normal proliferative
response following wounding or application of growth factors
(Kaya et al, 1997). The increased CD44 protein expression may
also contribute to the intracellular accumulation of hyaluronan
observed in the EGF-treated cultures.We postulate that hyaluro-
nan interacting with its receptors is associated with a stimulation
in epidermal proliferation, and may also serve as a survival signal
for keratinocytes and thus delay di¡erentiation.
In conclusion, EGF and TGF-b have opposite e¡ects on hya-
luronan content, Has2, Has3, and CD44 expression, proliferation,
and di¡erentiation in the organotypic REK culture. Further in-
vestigation is needed to reveal more precisely which aspects of
the biologic in£uences of the growth factors are mediated by hya-
luronan metabolism.
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